Vivos Therapeutics Inc (NASDAQ:VVOS) shares are trading lower by 26.1% to $3.05 during Thursday’s session after the company announced a $4.3 million registered offering of 1.36 million shares of ...

Vivos Therapeutics shares dropped Thursday after the company said it is offering 1.4 million common shares at $3.15 per share in a registered direct offering. Shares were down 27% to $3.03 in ...

Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of ...

Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos” or the "Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of highly ...

26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 92.3% of Iradimed shares are owned by institutional investors. 9.6% of Vivos Therapeutics shares are owned ...

LITTLETON, Colo. - Vivos Therapeutics, Inc. (NASDAQ: VVOS), a company specializing in treatments for sleep-related breathing disorders, announced today that the American Medical... ByInvesting.com ...

LITTLETON, Colo., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company ...

Vivos Therapeutics, Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing ...

Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the“Company”) (NASDAQ: VVOS) , a medical technology company specializing in the development and commercialization of ...